Cargando…
Economic Evaluation of First-Line Treatments for Metastatic Renal Cell Carcinoma: A Cost-Effectiveness Analysis in A Health Resource–Limited Setting
BACKGROUND: To estimate, from the perspective of the Chinese healthcare system, the economic outcomes of five different first-line strategies among patients with metastatic renal cell carcinoma (mRCC). METHODS AND FINDINGS: A decision-analytic model was developed to simulate the lifetime disease cou...
Autores principales: | Wu, Bin, Dong, Baijun, Xu, Yuejuan, Zhang, Qiang, Shen, Jinfang, Chen, Huafeng, Xue, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297611/ https://www.ncbi.nlm.nih.gov/pubmed/22412884 http://dx.doi.org/10.1371/journal.pone.0032530 |
Ejemplares similares
-
Subgroup Economic Analysis for Glioblastoma in a Health Resource-Limited Setting
por: Wu, Bin, et al.
Publicado: (2012) -
What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings?
por: Kenyon, Chris, et al.
Publicado: (2012) -
The Determinants of HIV Treatment Costs in Resource Limited Settings
por: Menzies, Nicolas A., et al.
Publicado: (2012) -
RAS testing and cetuximab treatment for metastatic colorectal cancer: a cost-effectiveness analysis in a setting with limited health resources
por: Wu, Bin, et al.
Publicado: (2017) -
Comparison of efficacy, safety, and quality of life between sorafenib and sunitinib as first-line therapy for Chinese patients with metastatic renal cell carcinoma
por: Cai, Wen, et al.
Publicado: (2017)